Form 8-K · Current report
Sherwin-Williams 8-K, filed Nov 2, 2026
- Filed
- CIK
- 0000089800
- Accession no.
- 0001193125-26-443395
Summary
The Sherwin-Williams Company entered into Amendment No. 2 to its amended and restated credit agreement with Citicorp USA, Inc., as administrative agent and issuing bank, and the lenders party thereto, adding $75 million of commitments for borrowing and letters of credit that mature on December 20, 2031.
Key points
- Amendment No. 2 adds $75,000,000 of additional commitments for borrowing and letters of credit under the credit agreement.
- The added commitments mature on December 20, 2031.
- Citicorp USA, Inc. acts as administrative agent and issuing bank, with the lenders party to the agreement.
- The amendment is filed as Exhibit 4.1 to the Form 8-K.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 1.01Entry into a Material Definitive Agreement
- 2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 9.01Financial Statements and Exhibits
From the filing
Item 1.01. Entry into a Material Definitive Agreement. On November 2, 2026, The Sherwin-Williams Company (“Sherwin-Williams”) entered into that certain Amendment No. 2 to the Amended and Restated Credit Agreement (“Amendment No. 2”) with Citicorp USA, Inc. (“CUSA”), as administrative agent and issuing bank, and the lenders party thereto. Amendment No. 2 amends that certain Amended and Restated Credit Agreement, dated as of November 17, 2025 (the “Credit Agreement”), among Sherwin-Williams, CUSA, as administrative agent and issuing bank, and the lenders party thereto. The primary purpose of Amendment No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.